Intercure Ltd. - stock earnings
INCR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 1.3 million USD | 27.8 million USD |
| 2023Q1 | 1.5 million USD | 29.3 million USD |
| 2022Q4 | 1.5 million USD | 30.0 million USD |
| 2022Q3 | 2.0 million USD | 28.3 million USD |
| 2022Q2 | 4.5 million USD | 27.5 million USD |
| 2022Q1 | -966467 USD | 25.1 million USD |
| 2021Q4 | -987657 USD | 25.6 million USD |
| 2021Q3 | -509551 USD | 19.1 million USD |
| 2021Q2 | 1.9 million USD | 13.9 million USD |
| 2021Q1 | 783555 USD | 9.9 million USD |
| 2020Q4 | 2.9 million USD | 8.4 million USD |
| 2020Q3 | 507029 USD | 6.6 million USD |
| 2020Q2 | -282536 USD | 3.2 million USD |
| 2020Q1 | -13.2 million USD | 1.2 million USD |
| 2019Q4 | -4.0 million USD | 528663 USD |
| 2019Q3 | -4.5 million USD | 750585 USD |
| 2019Q2 | -3.2 million USD | 778381 USD |
| 2019Q1 | 10.4 million USD | 475354 USD |
| 2018Q4 | -850938 USD | ? USD |
| 2018Q3 | -888118 USD | ? USD |
| 2018Q2 | -875723 USD | ? USD |
| 2018Q1 | -913771 USD | ? USD |
| 2017Q4 | -381305 USD | ? USD |
| 2017Q3 | -372595 USD | ? USD |
| 2017Q2 | -377337 USD | ? USD |
| 2017Q1 | -362196 USD | ? USD |
| 2016Q4 | -52985 USD | ? USD |
| 2016Q3 | 52118 USD | ? USD |
| 2016Q2 | -234540 USD | ? USD |
| 2016Q1 | 306999 USD | ? USD |
| 2015Q4 | -229792 USD | 12779 USD |
| 2015Q3 | -230219 USD | 85081 USD |
| 2015Q2 | 45144 USD | 121388 USD |
| 2015Q1 | -65031 USD | 138067 USD |
| 2014Q4 | -160082 USD | 264206 USD |
| 2014Q3 | -391156 USD | 287851 USD |
| 2014Q2 | -317567 USD | 380680 USD |
| 2014Q1 | -153249 USD | 587956 USD |
| 2013Q4 | -445016 USD | 671545 USD |
| 2013Q3 | -632639 USD | 469025 USD |
| 2013Q2 | -423453 USD | 516210 USD |
| 2013Q1 | -361668 USD | 676119 USD |
| 2012Q4 | -1.0 million USD | 504672 USD |
| 2012Q3 | 13.1 million USD | 471948 USD |
| 2012Q2 | -94293 USD | 554843 USD |
| 2012Q1 | -890157 USD | 642227 USD |
| 2011Q4 | -446655 USD | 792581 USD |
| 2011Q3 | -457883 USD | 812506 USD |
| 2011Q2 | -497485 USD | 882779 USD |
| 2011Q1 | -485735 USD | 861928 USD |
| 2010Q4 | -886486 USD | 933301 USD |
| 2010Q3 | -863812 USD | 909430 USD |
| 2010Q2 | -808262 USD | 850947 USD |
| 2010Q1 | -850814 USD | 895745 USD |
INCR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 12.7 million USD | 110.4 million USD |
| 2021 | 2.3 million USD | 70.7 million USD |
| 2020 | -11.2 million USD | 20.2 million USD |
| 2019 | -866453 USD | 2.6 million USD |
| 2018 | -3.4 million USD | ? USD |
| 2017 | -1.5 million USD | ? USD |
| 2016 | 68974 USD | ? USD |
| 2015 | -481887 USD | 359662 USD |
| 2014 | -974369 USD | 1.5 million USD |
| 2013 | -1.9 million USD | 2.4 million USD |
| 2012 | 11.6 million USD | 2.3 million USD |
| 2011 | -1.8 million USD | 3.2 million USD |
| 2010 | -3.5 million USD | 3.7 million USD |
INCR
Price: $2.66
52 week price:
Earnings Per Share: 0.12 USD
P/E Ratio: 12
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 6941
Ebitda: 98.4 millionMarket Capitalization: 107.6 million